๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

25 recruiting trials

for MTD

IKS014 in Advanced Solid Tumors That Express HER2 NCT05872295Phase 113 sites๐Ÿ“ Newport Beach๐Ÿ“ Boston๐Ÿ“ Nashville Iksuda Therapeutics Ltd. ยท Tests: IKS014 Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma NCT06487481Phase 11 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Surgical resection, Preoperative RT A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer NCT05093907Phase 1, Phase 21 site๐Ÿ“ Seoul BeyondBio Inc. ยท Tests: BEY1107, Capecitabine Momelotinib During and After HCT in Myelofibrosis NCT07104799Phase 11 site๐Ÿ“ Boston Massachusetts General Hospital ยท Tests: Momelotinib Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study NCT07708714Phase 1, Phase 21 site๐Ÿ“ Kampala Children's Hospital Medical Center, Cincinnati ยท Tests: hydroxycarbamide A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors NCT06292208Phase 1, Phase 21 site๐Ÿ“ Jinan SUNHO๏ผˆChina๏ผ‰BioPharmaceutical CO., Ltd. ยท Tests: IBD0333 Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ... NCT02390752Phase 11 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: TURALIO(R) IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas NCT05365659Phase 113 sites๐Ÿ“ Baltimore๐Ÿ“ Westmead๐Ÿ“ Adelaide Iksuda Therapeutics Ltd. ยท Tests: IKS03 Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma NCT03523975Phase 1, Phase 24 sites๐Ÿ“ Duarte๐Ÿ“ Ann Arbor๐Ÿ“ Columbus City of Hope Medical Center ยท Tests: Venetoclax, Lenalidomide, Rituximab This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile. NCT06756451Phase 116 sites๐Ÿ“ Hefei๐Ÿ“ Hefei๐Ÿ“ Guangzhou Nanjing RegeneCore Biotech Co., Ltd. ยท Tests: RJK-RT2831 dose-escalation phase Ia, RJK-RT2831 Dose Expansion Phase Ib Losartan + Sunitinib in Treatment of Osteosarcoma NCT03900793Phase 14 sites๐Ÿ“ Los Angeles๐Ÿ“ Aurora๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: Losartan, Sunitinib Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma NCT04234048Phase 110 sites๐Ÿ“ Scottsdale๐Ÿ“ Duarte๐Ÿ“ Los Angeles SciTech Development, Inc. ยท Tests: Fenretinide Actinium Therapy for Late-stage Aggressive Sarcomas NCT07156565Phase 16 sites๐Ÿ“ Los Angeles๐Ÿ“ Rochester๐Ÿ“ New York Ratio Therapeutics, Inc. ยท Tests: [Ac 225]RTX-2358, [Cu64]LNTH-1363S Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma NCT07061626Phase 11 site๐Ÿ“ Chicago Cerenome ยท Tests: Rhenium-186 Nanoliposome A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell Malignancies NCT05836896Phase 11 site๐Ÿ“ Dresden Technische Universitรคt Dresden ยท Tests: MDC-CAR-BCMA001 (BCMA directed CAR T-cells) A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study NCT05394714Phase 11 site๐Ÿ“ Taoyuan Medigen Biotechnology Corporation ยท Tests: Magicell-NK contains NK cells suspended in 100 mL normal saline ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers NCT07238075Phase 19 sites๐Ÿ“ Sydney๐Ÿ“ Sydney๐Ÿ“ Birtinya Adcytherix SAS ยท Tests: ADCX-020 Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes NCT07176988NA1 site๐Ÿ“ Atlanta Emory University ยท Tests: Hierarchical method, Non Hierarchical method A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab NCT07607678Phase 19 sites๐Ÿ“ New Haven๐Ÿ“ Hackensack๐Ÿ“ New York Boehringer Ingelheim ยท Tests: BI 3819026, Ezabenlimab (BI 754091) Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic Cancer NCT03579836Phase 1, Phase 21 site๐Ÿ“ Seoul BeyondBio Inc. ยท Tests: BEY1107, Gemcitabine A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects with Advanced Solid Tumors NCT05315167Phase 1, Phase 25 sites๐Ÿ“ Zhengzhou๐Ÿ“ Chengdu๐Ÿ“ Hangzhou Zhuhai Yufan Biotechnologies Co., Ltd ยท Tests: PRJ1-3024 A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM) NCT05769660Phase 11 site๐Ÿ“ Seoul BeyondBio Inc. ยท Tests: BEY1107, Temozolomide Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT) NCT01906385Phase 1, Phase 24 sites๐Ÿ“ Manhasset๐Ÿ“ Columbus๐Ÿ“ Dallas Cerenome ยท Tests: Rhenium Liposome Treatment SB17170 Phase 1 Clinical Trial in Solid Tumors NCT05522868Phase 13 sites๐Ÿ“ Seoul๐Ÿ“ Seoul๐Ÿ“ Seoul SPARK Biopharma ยท Tests: SB17170 This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors NCT04762641Phase 18 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Santa Monica ABL Bio, Inc. ยท Tests: ABL503
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy